Trials / Completed
CompletedNCT00004911
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
A Pilot Phase I/II Trial of Enteral Wallstents for Colonic Obstruction in the Setting of Malignancy
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: The use of endoscopy to place a metal stent in the large intestine is less invasive than surgery for treating cancer-related bowel obstruction and may have fewer side effects and improve recovery. PURPOSE: Phase I/II trial to study the effectiveness of endoscopic placement of a metal stent in treating patients who have cancer-related bowel obstruction.
Detailed description
OBJECTIVES: * Determine the objective response and clinical outcome in patients with colonic obstruction secondary to malignancy treated with enteral Wallstents. * Evaluate the efficacy and safety of this treatment in these patients. * Evaluate the quality of life of these patients after enteral Wallstent placement. OUTLINE: All patient undergo a colonoscopy, followed by placement of an enteral Wallstent through an endoscope under fluoroscopic guidance into the large intestine. Quality of life is assessed at 48 hours and 6 months after the procedure. Patients are followed at 48 hours, 30 days, 6 months, and then yearly thereafter until death. PROJECTED ACCRUAL: A total of 20 patients will be accrued for this study.
Conditions
- Colorectal Cancer
- Constipation, Impaction, and Bowel Obstruction
- Gastric Cancer
- Gastrointestinal Carcinoid Tumor
- Gastrointestinal Stromal Tumor
- Quality of Life
- Small Intestine Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | bowel obstruction management | |
| PROCEDURE | quality-of-life assessment |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2003-02-01
- Completion
- 2003-02-01
- First posted
- 2003-05-14
- Last updated
- 2012-06-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00004911. Inclusion in this directory is not an endorsement.